Mini-review: Polyamines metabolism, toxicity and potent therapeutical use

Anti-Infective Agents

Volumn 12, Issue 1, 2014, Pages 95-103

  Djouhri Bouktab, Lamia ^a   Rolain, Jean M ^a   Brunel, Jean M ^b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Anticancer activity; Antimicrobial activity; Metabolism; Polyamines; Therapeutical use

Indexed keywords

ABC TRANSPORTER; ACYLTRANSFERASE; AMIKACIN; AMOXICILLIN; CLAVULANIC ACID; DEXAMETHASONE; DISINFECTANT AGENT; DIZOCILPINE; ERYTHROMYCIN; IFENPRODIL; NOVOBIOCIN; ORNITHINE DECARBOXYLASE; POLYAMINE DERIVATIVE; POLYAMINE OXIDASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN P53; SPERMINE SYNTHASE; SQUALAMINE; STIGMASTEROL; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CELL PROLIFERATION; CYTOTOXICITY; DNA MODIFICATION; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; POLYAMINE METABOLISM; PROTEIN EXPRESSION; REVIEW; VIRUS REPLICATION;

EID: 84891822854     PISSN: 22113525     EISSN: 22113533     Source Type: Journal    
DOI: 10.2174/22113525113119990118     Document Type: Review

References (56)

1. Shah, P.; Swiatlo, E.A. multifaceted role for polyamines in bacterial pathogens. Mol. Microbiol., 2008, 68, 4-16.
2. Leeuwenhoek, D.A. De natise semine genitali animalculis. Philos. Trans. Roy. Soc., 1677, 12, 1040-1043.
3. Bachrach, U. The early history of polyamine research. Plant Physiol. Biochem., 2010, 48, 490-495.
4. Brieger, L. Weitere untersuchungen über ptmaine. Further investigations into ptomaines. 1885, 39-43.
5. Hu, J.; Mahmoud, M.I.; El-Fakahany, E.E. Polyamines inhibit nitric oxide synthase in rat cerebellum. Neurosci. Lett., 1994, 175, 41-45.
6. Wan, C.Y.; Wilkins, T.A. Spermidine facilitates PCR amplification of target DNA. PCR Methods Appl., 1993, 3, 208-210.
7. Cull, M.; McHenry, C.S. Preparation of extracts from prokaryotes. Methods Enzymol., 1990, 182, 147-153.
8. Blethen, S.L.; Boeker, E.A.; Snell, E.E. Argenine decarboxylase from Escherichia coli. I. Purification and specificity for substrates and coenzyme. J. Biol. Chem., 1968, 243, 1671-1677.
9. Wu, W.H.; Morris, D.R. Biosynthetic arginine decarboxylase from Escherichia coli. Subunit interactions and the role of magnesium ion. J. Biol. Chem., 1973, 248, 1696-1699.
10. Tabor, C.W.; Tabor, H. Polyamines. Annu. Rev. Biochem., 1984, 53, 749-790.
11. Krug, M.S.; Berger, S.L. First-strand cDNA synthesis primed with oligo (dT). Methods Enzymol., 1987, 152, 316-325.
12. Karkas, J.D.; Margulies, L.; Chargaff, E. A DNA polymerase from embryos of Drosophila melanogaster. Purification and properties. J. Biol. Chem., 1975, 250, 8657-8663.
13. Bouche, J.P. The effect of spermidine on endonuclease inhibition by agarose contaminants. Anal. Biochem., 1981, 115, 42-45.
14. Eisenberg, T.; Knauer, H.; Schauer, A.; Büttner, S.; Ruckenstuhl, C.; Carmona-Gutierrez, D.; Ring, J.; Schroeder, S.; Magnes, C.; Antonacci, L.; Fussi, H.; Deszcz, L.; Hartl, R.; Schraml, E.; Criollo, A.; Megalou, E.; Weiskopf, D.; Laun, P.; Heeren, G.; Breitenbach, M.; Grubeck-Loebenstein, B.; Herker, E.; Fahrenkrog, B.; Fröhlich, K.U.; Sinner, F.; Tavernarakis, N.; Minois, N.; Kroemer, G.; Madeo, F. Induction of autophagy by spermidine promotes longevity. Nat. Cell Biol., 2009, 11, 1305-1314.
15. Palmer, A.J.; Wallace, H.M. The polyamine transport system as a target for anticancer drug development. Amino Acids, 2010, 38, 415-422.
16. De bandt, J.P.; Moinard, C.; Cynober, L. metabolisme et fonctions des polyamines. Immunoanal. Biol. Special., 2006, 21, 333-341.
17. Igarashi, K.; Kashiwagi, K. Characteristics of cellular polyamine transport in prokaryotes and eukaryotes. Plant Physiol. Biochem., 2010, 48, 506-512.
18. Kaier, K.; Wilson, C.; Chalkley, M.; Davey, P.G.; Suetens, C.; Grundmann, H.; de Kraker, M.; Schumacher, M.; Wolkewitz, M.; Frank, U. Health and economic impacts of antibiotic resistance in European hospitals-outlook on the BURDEN project. Infection, 2008, 36, 492-494.
19. Armstrong, D.; Neu, H.; Peterson, L.R.; Tomasz, A. The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s. Microb. Drug Resist, 1995, 1, 1-4.
20. Seiler, N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect. and prospect. Part 1. Selective enzyme inhibitors. Curr. Drug Targets, 2003, 4, 537-564.
21. Zou, T.; Rao, J.N.; Liu, L.; Xiao, L.; Cui, Y.H.; Jiang, Z.; Ouyang, M.; Donahue, J.M.; Wang, J.Y. Apoptosis polyamine: Polyamines inhibit the assembly of stress granules in normal intestinal epithelial cells regulating apoptosis. Am. J. Physiol. Cell Physiol., 2012, 303, C102-C111.
22. Tabib, A.; Bachrach, U. Stimulation of transcription: Role of polyamines in mediating malignant transformation and oncogene expression. Int. J. Biochem. Cell Biol., 1999, 31, 1289-1295.
23. Sharmin, S.; Sakata, K.; Kashiwagi, K.; Ueda, S.; Iwasaki, S.; Shirahata, A.; Igarashi, K. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem. Biophys. Res. Commun., 2001, 282, 228-235.
24. Sakata, K.; Kashiwagi, K.; Sharmin, S.; Ueda, S.; Igarashi, K. Acrolein produced from polyamines as one of the uraemic toxins. Biochem. Soc. Trans., 2003, 31, 371-374.
25. Hill, I.R.; Garnett, M.C.; Bignotti, F.; Davis, S.S. In vitro cytotoxicity of poly (amidoamine) s, relevance to DNA delivery. Biochim. Biophys. Acta, 1999, 1427, 161-174.
26. Sparapani, M.; Dall'Olio, R.; Gandolfi, O.; Ciani, E.; Contestabile, A. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells. Exp. Neurol., 1997, 148, 157-166.
27. de Verra, N.; Martinez, E.; Sanfeliu, C. Spermine induces cell death in cultured human embryonic cerebral cortical neurons through N-methyl-D-aspartate receptor activation. J. Neurosci. Res., 2008, 86, 861-872.
28. Fukuchi, J.; Kashiwagi, K.; Kusama-Eguchi, K.; Terao, K.; Shirahata, A.; Igarashi, K. Mechanism of the inhibition of cell growth by N1, N12-bis (ethyl) spermine. Eur. J. Biochem., 1992, 209, 689-696.
29. Bachrach, U.; Rosenkovitch, E. Effect of oxidized spermine and other aldehydes on the infectivity of vaccinia virus. Appl. Microbiol., 1972, 23, 232-235.
30. Bachrach, U. Antiviral activity of oxidized polyamines. Amino Acids, 2007, 33, 267-272.
31. Mibu, N.; Yokomizo, K.; Oishi, M.; Miyata, M.T.; Sumoto, K. Synthesis and antiviral activities of N-mono-and/or N, N'-dicarbamoyl and acyl derivatives of symmetrical diamines. Chem. Pharm. Bull., 2008, 56, 1052-1058.
32. Zasloff, M.; Adams, A.P.; Beckerman, B.; Campbell, A.; Han, Z.; Luijten, E.; Meza, I.; Julander, J.; Mishra, A.; Qu, W.; Taylor, J.M.; Weaver, S.C.; Wong, G.C. Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proc. Natl. Acad. Sci. USA, 2011, 108, 15978-15983.
33. Chadwick, J.; Jones, M.; Mercer, A.E.; Stocks, P.A.; Ward, S.A.; Park, B.K.; O'Neill, P.M. Design, synthesis and antimalarial/ anticancer evaluation of spermidine linked artemisinin conjugates designed to exploit polyamine transporters in Plasmodium falciparum and HL-60 cancer cell lines. Bioorg. Med. Chem., 2010, 18, 2586-2597.
34. Salmi, C.; Loncle, C.; Vidal, N.; Rogier, C.; Letourneux, Y.; Pradines, B.; Brunel, J.M. 3-Aminosterol Compounds as a New Class of Anti-Malarial Agents against Chloroquine-Susceptible and-Resistant Plasmodium falciparum. Lett. Drug Design Discov., 2009, 6, 163-166.
35. Moore, K.S.; Wehrli, S.; Roder, H.; Rogers, M.; Forrest, J.N. Jr; McCrimmon, D.; Zasloff, M. Squalamine, an aminosterol antibiotic from the shark. Proc. Natl. Acad. Sci. USA, 1993, 90, 1354-1358.
36. Alhanout, K.; Brunel, J.M.; Ranque, S.; Rolain, J.M. In vitro antifungal activity of aminosterols against moulds isolated from cystic fibrosis patients. J. Antimicrob. Chemother., 2010, 65, 1307-1309.
37. Alhanout, K.; Djouhri, L.; Vidal, N.; Brunel, J.M.; Piarroux, R.; Ranque, S. In vitro activity of aminosterols against yeasts involved in blood stream infections. Med. Mycol., 2011, 49, 121-125.
38. Salmi, C.; Loncle, C.; Vidal, N.; Letourneux, Y.; Fantini, J.; Maresca, M.; Taïeb, N.; Pagès, J.M.; Brunel, J.M. Squalamine, an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? PLoS One, 2008, 3, e2765.
39. Shu, Y.; Jones, S.R.; Kinney, W.A.; Selinsky, B.S. The synthesis of spermine analogs of the shark aminosterol squalamine. Steroids, 2002, 67, 291-304.
40. Khan, S.N.; Jung, Y.M.; Kim, B.J.; Cho, H.; Lee, J.; Kim, H.S. Synthesis and antimicrobial activity of 7 alpha-amino-23, 24-bisnor-5 alpha-cholan-22-ol derivatives. Bioorg. Med. Chem. Lett., 2008, 18, 2558-2561.
41. Khan, S.N.; Kim, H.S. Synthesis and biological activities of 3-polyamino-5-beta cholane-7 alpha, 24 diols. J. Indus. Eng. Chem., 2009, 15, 561-565.
42. Kim, H.S.; Khan, S.N.; Jadhav, J.R.; Jeong, J.W.; Jung, K.; Kwak, J.H. A concise synthesis and antimicrobial activities of 3-polyamino-23, 24-bisnorcholanes as steroid-polyamine conjugates. Bioorg. Med. Chem. Lett., 2011, 21, 3861-3865.
43. Kikuchi, K.; Bernard, E.M.; Sadownik, A.; Regen, S.L.; Armstrong, D. Antimicrobial activities of squalamine mimics. Antimicrob. Agents Chemother., 1997, 41, 1433-1438.
44. Loncle, C.; Salmi, C.; Letourneux, Y.; Brunel, J.M. Synthesis of new 7-aminosterol squalamine analogues with high antimicrobila activities through a stereoselective titanium reductive amination reaction. Tetrahedron, 2007, 63, 12968-12974.
45. Salmi, C.; Loncle, C.; Vidal, N.; Letourneux, Y.; Brunel, J.M. New stereoselective titanium reductive amination synthesis of 3-amino and polyaminosterol derivatives possessing antimicrobial activities. Eur. J. Med. Chem., 2008, 43, 540-547.
46. Alhanout, K.; Brunel, J.M.; Raoult, D.; Rolain, J.M. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis. J. Antimicrob. Chemother., 2009, 64, 810-814.
47. Selinsky, B.S.; Smith, R.; Frangiosi, A.; Vonbaur, B.; Pedersen, L. Squalamine is not a proton ionophore. Biochim. Biophys. Acta, 2000, 1464, 135-141.
48. Alhanout, K.; Malesinki, S.; Vidal, N.; Peyrot, V.; Rolain, J.M.; Brunel, J.M. New insights into the antibacterial mechanism of action of squalamine. J. Antimicrob. Chemother., 2010, 17, 3909-3917.
49. Di pasquale, E.; Salmi-Smail, C.; Brunel, J.M.; Sanchez, P.; Fantini, J.; Maresca, M. Biophysical studies of the interaction of squalamine and other cationic amphiphilic molecules with bacterial and eukaryotic membranes, importance of the distribution coefficient in membrane selectivity. Chem. Phys. Lipids, 2010, 163, 131-140.
50. Yasuda, K.; Ohmizo, C.; Katsu, T. Mode of action of novel polyamines increasing the permeability of bacterial outer membrane. Int. J. Antimicrob. Agents, 2004, 24, 67-71.
51. Lavigne, J.P.; Brunel, J.M.; Chevalier, J.; Pages, J.M. Squalamine, an original chemosensitizer to combat antibiotic-resistant gramnegative bacteria. J. Antimicrob. Chemother., 2010, 65, 799-801.
52. Balakrishna, R.; Wood, S.J.; Nguyen, T.B. Structural correlates of antibacterial and membrane-permeabilizing activities in acylpolyamines. Antimicrob. Agents Chemother., 2006, 50, 852-861.
53. Fein, D.E.; Bucki, R.; Byfield, F.; Leszczynska, K.; Janmey, P.A.; Diamond, S.L. Novel cationic lipids with enhanced gene delivery and antimicrobial activity. Mol. Pharmacol., 2010, 78, 402-410.
54. Bucki, R.; Leszczynska, K.; Byfield, F.J. Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasonespermine conjugate. Antimicrob. Agents Chemother., 2010, 54, 2525-2533.
55. McDonnell, G.; Russell, A.D. Antiseptics and disinfectants, activity, action, and resistance. Clin. Microbiol. Rev., 1999, 12, 147-179.
56. Djouhri-Bouktab, L.; Alhanout, K.; Andrieu, V.; Raoult, D.; Rolain, J.M.; Brunel, J.M. Squalamine ointment for Staphylococcus aureus skin decolonization in a mouse model. J. Antimicrob. Chemother., 2011, 66, 1306-1310.